Latest News

Latest News

The latest news on fibromyalgia syndrome and chronic fatigue syndrome is posted below in support of Fibromyalgia Network’s mission to educate patients and the media with ad-free reporting.

Phone: (520) 290-5508 • E-mail: editor@fmnetnews.com
Website: www.fmnetnews.com • Facebook: www.facebook.com/FibroNetwork

FDA Approves Lyrica, First Drug to Treat Fibromyalgia

The FDA approved Lyrica (pregabalin) as the first drug with an indicated use for people with fibromyalgia.

Read the complete article.

Is Caffeine Disrupting Your Sleep?

Does it really matter if you have just a little bit of caffeine-containing chocolate dessert before you go to bed at night?

Read the complete article.

IACFS Presents Special Service Award to Kristin Thorson

IACFS recognizes Fibromyalgia Network and American Fibromyalgia Syndrome Association founder for substantial contributions.

Read the complete article.

Study Links Fibromyalgia to Metabolic Disease

Patients with fibromyalgia or chronic fatigue syndrome may be at greater risk for metabolic disease, new research shows.

Read the complete article.

Board Changes Name of Chronic Fatigue Syndrome

Chronic fatigue syndrome patients have fought for ten years to get the name of their condition changed.

Read the complete article.

 

All information on this site is copyrighted by
Fibromyalgia Network, P.O. Box 31750, Tucson, AZ 85751 (520) 290-5508.
This site is provided for informational purposes only. To remain unbiased, we do not accept endorsements, advertisements,
or pharmaceutical industry grants. Patients should always consult their physician for medical advice and treatment.